Tag Archives: 5mg tablet

European Commission Approves New Evrysdi Tablet, Offering Enhanced Flexibility for SMA Treatment

(IN BRIEF) Roche announced the European Commission’s approval of a label extension for Evrysdi® (risdiplam) to include a new 5mg tablet, offering a room-temperature stable alternative to the original oral solution for individuals with spinal muscular atrophy (SMA). The tablet, … Read the full press release